Shin‐Shay Tian - Concepedia

Author

Shin‐Shay Tian

Genomics Institute of the Novartis Research Foundation

Also Known As

Shin-Shay Tian, Shin‐Shay Tian

Publications

Citations

H-Index

Concepts

All Affiliations

Genomics Institute of the Novartis Research Foundation Ligand Pharmaceuticals (United States)GlaxoSmithKline (United States)Novartis (United Kingdom)South College

About

Shin‐Shay Tian is an author at Genomics Institute of the Novartis Research Foundation specializing in medicine, pharmacotherapy, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	11	11	861
2	Biochemistry	6	6	297
3	Natural Sciences	5	5	268
4	Cell Biology	4	4	483
5	Immunology	3	3	502

Shin‐Shay Tian

Publications

Citations

H-Index

Page 1

	Year	Citations
Preclinical Activity of Eltrombopag (SB-497115), an Oral, Nonpeptide Thrombopoietin Receptor Agonist Connie L. Erickson‐Miller, Evelyne Delorme, Shin‐Shay Tian, Stem Cells Platelet NumbersImmunologyBlood CellIncreased Platelet ProductionPharmacotherapy	2008	280
Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonist Connie L. Erickson‐Miller, Evelyne Delorme, Shin‐Shay Tian, Experimental Hematology ThrombopoiesisThrombosisSignal TransductionFunctional SelectivityMedicine	2005	202
Hydrazinonaphthalene and Azonaphthalene Thrombopoietin Mimics Are Nonpeptidyl Promoters of Megakaryocytopoiesis Kevin J. Duffy, Michael G. Darcy, Evelyne Delorme, Journal of Medicinal Chemistry Drug TargetMolecular BiologyPharmacotherapyEpigeneticsMedicinal Chemistry	2001	119
NMR Structural Studies of Interactions of a Small, Nonpeptidyl Tpo Mimic with the Thrombopoietin Receptor Extracellular Juxtamembrane and Transmembrane Domains Minju Kim, Sang‐Ho Park, Stanley J. Opella, Journal of Biological Chemistry Proteinlipid InteractionReceptor Domain SwapMolecular BiologyReceptor Tyrosine KinaseGlycoprotein Growth Factor	2007	64
Increased prokineticin 2 expression in gut inflammation: role in visceral pain and intestinal ion transport Robert P. Watson, Elliot Lilley, Moh Panesar, Neurogastroenterology & Motility	2011	46
Novel Bisaryl Substituted Thiazoles and Oxazoles as Highly Potent and Selective Peroxisome Proliferator-Activated Receptor δ Agonists Robert Epple, Christopher Cow, Xie Yongping, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryBiochemistryFunctional SelectivityMedicine	2009	42
1,3,5-Trisubstituted aryls as highly selective PPARδ agonists Robert Epple, Mihai Azimioara, Ross Russo, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyFunctional SelectivityMedicineMechanism Of ActionPharmacotherapy	2006	38
Species Specificity and Receptor Domain Interaction of a Small Molecule TPO Receptor Agonist. Connie L. Erickson‐Miller, Evelyn Delorme, Maya Iskander, Blood	2004	35
Biological Activity and Selectivity for Tpo Receptor of the Orally Bioavailable, Small Molecule Tpo Receptor Agonist, SB-497115. Connie L. Erickson‐Miller, Evelyn Delorme, Leslie Giampa, Blood	2004	32
3,4,5-Trisubstituted isoxazoles as novel PPARδ agonists. Part 2 Robert Epple, Mihai Azimioara, Ross Russo, Bioorganic & Medicinal Chemistry Letters Molecular PharmacologyBiochemistryMedicine3,4,5-Trisubstituted IsoxazolesMechanism Of Action	2006	29

Page 1